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BASAL CELL EPITHELIOMAS AND OTHER SKIN TUMORS PRODUCED IN
RATS AND MICE BY ANTHRAMINE AND METHYLCHOLANTHRENE*
HERSCHEL S. ZACEHEIM, M.D., WILLIAM L. SIMPSON, M.D. AND LENORE LANGS, B.S.
The principal purpose of this report is to draw
further attention to the wide variety of skin
tumors that can be produced in the rat by the
topical application of 2-anthramine with particu-
lar attention to basal cell epitheliomas. Some
observations will also be reported on tumors pro-
duced by methylcholanthrene in rat skin, and by
anthramine and methylcholanthrene in mouse
skin. The contrast between anthramine and
methylcholanthrene in these 2 species is part of
a program aimed at understanding species dif-
ferences in susceptibility to carcinogens. Effects
of these carcinogens on connective tissue ele-
ments, especially tissue mast cells, have already
been reported.t
2-Anthramine (2-aminoanthracene) is prepared
by the reduction of 2-aminoanthraquinone (1).
It is chemically related to other carcinogenic
aromatic amines as 2-acetylaminofluorene
(AAF), 4-aminostilbene and 2-naphthylamine.
Bielschowsky in 1946 (2) described basal cell epi-
theliomas in 4 of 18 rats painted with anthra-
mine. With a larger series of rats, Lennox in
1955 (3) reported a high percentage of dermal
sarcomas and epithelial tumors including
squamous, basal and sebaceous epitheliomas pro-
duced with topical anthramine. In mice, Lennox
found a lower percentage of tumors, all squamous
cell, of which 2 were carcinomas.
Bachmann (1937) (4) observed basal cell epi-
theliomas in 2 rats painted with methylcholan-
threne, and Teir (1954) (5) reported basal and
squamous epitheliomas and fibrosarcomas in
rats painted with methylcholanthrene and re-
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ceiving injections of skin suspensions of newborn
rats. The production of squamous cell carcinomas
in mice by topical methylcholanthrene is well
known.
EXPERIMENT I. ANTHRAMINE TREATED RAT5
Methods
Anthramine is a yellow powder and is soluble
to approximately 1% as a saturated solution in
acetone.* The fresh solution is yellow brown but
darkens on standing. It was freshly made every 2
or 3 weeks and kept in a refrigerator. It has a pale
green fluorescence. The saturated (approximately
1%) solution was used in all our experiments.
Twenty-four albino Fisher rats, 18 males and 6
females, were painted with anthramine for 180 to
FIG. 1. Multiple tumors on back of rat painted
with anthramine for 382 days, (A-5, 1).
401 days until sacrificed. The solution was applied
to the unshaved and unepilated midback region
twice weekly, with either a brush or a syringe
and blunt needle (Table I). The usual dose was
0.15 cc. and at this level no significant toxic symp-
toms were noted. In the rat no hair loss occurred
for at least 6 to 7 months. Thereafter thinning was
progressive and alopecia was usually present in
the areas of tumor formation.
Tumors
Most of the tumors were grossly visible S to
10 months after onset of treatment (Fig. 1). A
* 2-anthramine was initially prepared for us by
Dr. Jerome Horwitz of the Detroit Institute of
Cancer Research, and more recently by the
Aldrich Chemical Co., Milwaukee 10, Wisconsin.
t.it
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TABLE I
24 anthramine rats
Tumor Died or Prickle Cell Prickle Cell Basal Cell Sebaceous Sebaceous "Cylin- Fibro-
Noted (days) Sacrificed Papilloma Epith.* Epith. Adenoma Epith. droma" sarcoma
Series A3. Fisher albino male rats, 4 months old. 1% Anthramine solution to midback, 2X/week.
Dosage: .02 cc., grad. increased to .15 cc. by 185th day
11-5
11-7
I-i
1-4
11-2
11-4
1-6
1-5
1-2
11-6
—
—
238
276
245
245
245
276
251
303
192
216
314
324
338
360
380
394
401
401
—
—
—
—
—
—
—
+
+
+
—
—
—
+ (I)
—
+ (III)
+ (II)
+ (II)
+ (IV)
—
+ —
+ —
+ +
+ +
+ +
+ —
+ —
+ —
+ —
+ +
—
—
+
—
+
—
+
—
—
—
—
—
—
—
—
—
—
+
+
—
—
—
—
+
—
+
+t
+
Series A5. Fisher albino male rats, 2 months old. Dosage: .15 cc. 2X/week
111-3
111-2
111-6
111-i
253 320
344 344
253 382
272 382
—
—
—
—
+ (I)
+ (III)
+ (II)
+ (I)
+
+
+
+
+ —
— —
+ —
— —
—
—
—
+
—
—
—
—
,27
3135
Series A7. Fisher albino male rats, 5 months old. Dosage: .15 cc. 2X/week
— 180
— 210
— 240
—
—
—
—
—
—
—
+
—
—
—
—
—
—
—
—
—
—
—
—
—
Series RH. Fisher albino rats, 6 9, one o (1175), 5 to 8 months old. Dosage: 0.1 cc. 2X/week to 90
days, 0.2 cc. to 210 days, then 0.3 cc.
1172
1173
1175
1176
1196
1197
H98
—
—
—
—
—
301
305
186
186
188
211
300
301
305
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
+
+
—
+
+
+
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
Totals 24 3 9 20 6 3 3 4
* Broders grade in parentheses
Primarily a myxosarcoma, with some osteoid tissue
wide variety of epithelial and connective tissue
tumors was found (Tables I and II). Basal cell
epitheliornas were the most common, occurring in
20 rats; prickle cell epitheliomas occurred in 9,
and fibrosarcomas in 4. Sebaceous adenomas
were found in 6 and sebaceous epitheliomas in 3.
Three rats showed features suggestive of human
cylindrornas, and 3 had verrucous squamous
papillomas. These are described in detail below.
Nine had both squamous and basal cell epi-
theliomas.
Our usage of the term "basal cell epithelioma"
refers to any abnormal proliferation of "basal"
cells by which we mean cells having round, oval
or spindle shaped deeply staining basophilic
nuclei with scanty cytoplasm and indistinct cell
boundaries. With hematoxylin and eosin prep-
arations these cell masses have a characteristic
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deep purple color. For convenience we also use
the term "basalioma" synonymously with basal
cell epithelioma.
Many of the varieties of basal cell epitheliomas
that have been described for humans were found
in the rats. These include the superficial type,
solid nests, keratotic forms, infiltrating cords and
networks and other varieties.
The earliest forms of basaliomas were pro-
liferations almost within and budding downward
from the epidermis (Fig. 2). Several of these buds
could often be seen in the same section and there
was usually an increase in young fibroblastic
proliferation in the underlying cutis (Fig. 3).
Early infiltrations of basal cells were embedded
in a loose cellular connective tissue (Fig. 4). In
more advanced lesions, large solid nests were
found in the cutis (Fig. 5). With an increase in
size, there was often liquefaction degeneration
of the center of these nests. Other basal cell
proliferations were surrounded by denser con-
nective tissue sheaths forming small encapsu-
lated nests (Fig. 6). These connective tissue
capsules and septa reacted positively with the
periodic acid-Schiff stain and resisted digestion
with diastase. The cells within these capsules
often showed loss of stainable material in the
cytoplasm giving the appearance of "clear"
cells. A further degenerative change showed
shrinkage of nuclei and the presence of small
hyalin droplets.
Small keratin whorls were often found within
basal cell masses (Fig. 7), and there were also
other areas of large keratin cyst formation sug-
gesting the picture of trichoepithelioma (Fig. 8).
Networks of infiltrating cords and strands of
basal cells were present (Fig. 9).
Toluidin blue stains (pH 4.5) usually showed
some metachromatic material in the stroma of
the basal cell nests. No increase in mast cells was
found around the nests.
Sections somewhat resembling human cylin-
dromas were found in 3 rats. These showed hyalin
degeneration of basal cell nests with palisade
TABLE II
24 anthranzine rats
(painted 180—401 days)
Basal cell epithelioma 20
Sebaceous adenoma 6
Sebaceous epitheliomna 3
"Cylindroma" 3
Prickle cell epithelioma 9
Prickle cell papillomna 3
Fibrosareoma (myxosarcoma 1) 4
Having both BCE* and PCEf 9
No tumors 4
* BCE—Basal Cell Epithelioma
f PCE—Prickle Cell Epithelioma
FIG. 2. Superficial nest of basal cells in rat painted with anthramine for 305 days, (1198-A). H&E,
185X.
2
4.
388 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
FIG. 3. Downward budding of basal cell nests into upper cutis. Note accompanying fibroblastic pro-
liferation. From same rat as in Fig. 2, (1198-A). H&E, 185X.
FIG. 4. Small strands of basal cells embedded in
loose, cellular connective tissue. Same rat as in
Fig. 2. (1198-A). 11&E, 90X.
formation. There was some hyalinization of the
connective tissue septa as well as of the cells
within the nests. Liquefaction degeneration
within the larger nests was present (Figs. 10,
11, 12).
Sebaceows adenomas were found in 6 rats. These
ranged from medium sized proliferations of
sebaceous cells and the germinative cells of the
sebaceous glands (Fig. 13) to large lobulated
lesions (Fig. 14). Some of these tumors were
stained with Sudan Black on frozen sections and
were positive for lipids. We classified three
lesions as sebaceous epitheliomas. These are solid
basal cell nests with sebaceous differentiation
(Fig. 15).
Prickle cell epitheliomas were found in 9 of the
24 rats. These ranged from early well differen-
tiated Broder's grade I to grade IV anaplastic
forms (Fig. 16). In addition, 3 showed verrucous
prickle cell papillomas. Prickle cell hyperplasia
was often found overlying areas of basal cell
proliferations, and prickle cell epitheliomas could
be found directly adjacent to basal cell growths
(Fig. 17).
Fibrosarcomas were found in 4 rats (Fig. 18).
In one of these, the sarcomatous cells were em-
bedded in a loose mucoid connective tissue sug-
gesting a myxosarcoma (Fig. 19). Osteoid tissue
was found in one fibrosarcoma.
Basaliomas appear to be the first neoplasms
to develop in the anthramine treated rats. The
earliest lesions were small basal cell growths in
rats sacrificed at 186, 188 and 192 days without
gross tumors. Prickle cell epitheliomas occurred
only in rats which also had basaliomas. Nine rats
in which tumors of the basal cell group only
(including sebaceous adenomas and epitheliomas)
occurred were painted from 186 to 314 days, with
a mean time of 246 days. Nine rats in which
0
3
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FIG. 5. Solid basal cell nest in upper cutis in anthramine painted rat, 276 days, (11-6), H&E, 185X
prickle cell epitheliomas occurred in addition to
basal and other types of tumors had been painted
from 324 to 401 days, with a mean time of 365
days.
Sections from the lungs, liver, kidney, spleen,
and in most instances, lymph nodes were studied
from 10 rats sacrificed at 314 days and later. No
metastases were found
EXPERIMENT II. ANTIJEAMINE TREATED MICE
Methods
The 1% anthramine solution was applied to the
unshaved and unepilated midback twice weekly
with either a brush or a syringe and a blunt needle.
The dosage was for the most part .025 cc. for 30
days and then .05 cc. until death or sacrifice. In
series Al a dose of 0.1 cc. was attempted, but it was
found that the mice were losing weight at this level
so the dose was cut to .05 cc. (Table III).
Tumors
Of 29 mice surviving or sacrificed from 202 to
484 days, 3 developed prickle cell papillomas, 20
had prickle cell epitheliomas, and one also had a
fibrosarcoma (Table IV). No basaliomas, se-
FIG. 6. Encapsulated basal cell nests. Anthra-
mine painted rat, 311 days, (1-2, 10). H&E, 90X.
baceous adenomas, or other neoplasms were
found. The squamous epitheliomas ranged from
well differentiated to anaplastic types. The mean
time of occurrence of these tumors was 380 days,
which is considerably longer than that required
by methylcholanthrene paintings.
Hair loss was noted earlier in the mice than in
the rats, and was usually complete in the treated
area within approximately 3 months.
U'
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FIG. 7. Keratin whorls within solid basal cell nests. Anthramine painted rat, 314 days, (I-i). ll&E,
185X.
Tumors
FIG. 8. Keratin cysts in basal cell epithelioma,
suggesting a trichoepithelioma. Anthramine
painted rat, 311 days, (1-2, 10). H&E, 00X.
EXPERIMENT III. METIIYLCHOLANTIIRENE TREATED
RATS
Methods
Twelve albino Fisher male rats were painted on
the unshaved and unepilated midback region with
a 0.3% solution of methyleholanthrene in acetone,
approximately 0.2 to 0.3 cc. 3 times a week. One
was sacrificed every 30 days until 330 days.
This experiment was part of a comparative
study of early changes in the skin produced by
anthramine and methylcholanthrene in the rat
and mouse. These early changes are described in
Exp. IV.
To our surprise 5 of the 6 rats painted 180 days
or longer developed lesions which we regard as
basal cell epitheliomas, and in addition one also
had a verrucous prickle cell epithelioma (Table
V). Small prolifcrations of basofilic cells were
found apparently arising from the epidermis
(Fig. 20) and from deep portions of the hair
follicles (Fig. 21). One rat showed 2 deep nests
just above the panniculus carnosus (Fig. 22). A
rat painted 330 days had 2 large basal cell nests
with liquefaction degeneration (Fig. 23) and a
verrucous grade I squamous epithelioma.
EXPERIMENT iV. COMPARATIVE 5TUBY OF EARLY
CHANGES INDUCED BY ANTHRAMINR AND
METHYLCHOLANTRRENE IN RATS AND MICE
The purpose of this study was to detect any
pre-ncoplastic changes that might be induced by
either anthramine or methylcholanthrene in rat
or mouse skin. Twelve albino Fisher male rats were
painted twice weekly to the midback with 0.15
';.
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Fm.9. InfiltratIng basal cell networks. Note very cellular stroma. Anthramine painted rat, 314days
(1-5, is). HeR,90X.
Fm. 10. Basal cell epithafinina with palisade formation and hyalin degeneration of celia witbin aoma
of the nests suggesting a eylindrcma. Anthramine painted rat, 401 days, (114, 7a). Hell, 45X.
- •10
392 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
FIG. 11. High power of triangular shaped nest at base (A) in Fig. 10,showing hyalin degeneration of
cells within the nest. H&E, 280X.
FIG. 12. Hyalinization of basal cell nests. Liquefaction of very large basal cell mass seen on the left.
Same rat as in Fig. 10, (11-6, 3a). H&E, 185X.
•
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FIG. 13. Sebaceous adenoma. Anthramine painted rat, 314 days, (I-i). H&E, 90X
FIG. 14. Sebaceous adenoma. This is from a large, lobulated lesion. Anthramine painted rat, 324 days,
(1-4, Ga). H&E, 90X.
13
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FIG. 15. Sebaceous epithelioma. Note scattered sebaceous cells throughout basal cell nests. Anthra-
mine painted rat, 286 days, (I-i). H&E, 90X.
FIG. 16. Anaplastic squamous cell carcinoma. Anthramine painted rat, 360 days, (11-4, 3a). H&E,00x.
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FIG. 17. Large area of basal cell nests on left and prickle cell hyperplasia on right. Anthramine painted
rat, 380 days, (1-6, Ga). H&E, 30X.
FIG. 18. Fibrosarcoma. Anthramine painted rat, 314 days, (1-5, la). H&E, flUX
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FIG. 19. Myxosarcoma. Sarcomatous cells embedded in loose, mucoid connective tissue. Strong
metachromasia with toluidin blue. Anthramine painted rat, 311 days, (1-2, 10). H&E, 90X.
cc. of 1% anthramine and a second group of 12
was painted with 0.2—0.3 cc. of 0.3% methyl-
cholanthrene in acetone to the midback 3 times
a week. Twelve C-albino male mice were painted
with .05 cc. of 1% anthramine twice weekly to
the midback, and a second group of 12 was
painted with 0.1 cc. of 0.3% methylcholanthrene
3 times a week to the midback. Biopsy specimens
were taken at approximately 30 day intervals on
one animal each in the 4 groups. Sections were
stained with hematoxylin-eosin, toluidin blue,
and periodic acid-Schiff, and were also tested
histochemically for non-specific esterases and
succinic dehydrogenase.
Anthramine Treated Rats
Biopsy specimens were taken up to 240 days.
No epidermal changes were noted for the first 5
months. Spotty mild acanthosis was noted from
the sixth month on. Mild hyperkeratosis with
keratotic plugging of follicular openings and
small keratin cysts in the upper cutis was noted
in varying degree from the sixth month on. A
small nest of basal cells arising from the epi-
dermis was noted at 210 days. No significant
changes were noted in the hair follicles or Se-
baceous glands, which were present in all sec-
tions, or in the dermis. There was no increase in
mast cells.
Anthramine Treated Mice
Biopsy specimens were taken up to 330 days.
Spotty mild epidermal acanthosis was noted
from the fifth month on and a prickle cell papil-
loma was present at 210 days. Areas of sparse
hair follicles and sebaceous glands were found in
most of the monthly biopsies from the second
month on. There was no increase in mast cells or
other noticeable changes in the cutis.
Methyicholanthrene Treated Rats
Biopsy specimens were taken up to 330 days,
and it was in this group that the 5 basaliomas and
one squamous epithelioma were found. (See
Exp. III.) No epidermal changes were otherwise
noted. There was some keratotic follicular plug-
ging with small cyst formation from the fifth
month on. Sebaceous glands were present in all
sections. Hair follicles were also present and ap-
peared normal except where they seemed to be
the site of basal cell proliferations. The cutis was
.s,4±t- -a:
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TABLE III
29 anthramine mice
1% anthramine solution applied 2X/week to
midback.
Tumor
Noted
(days)
Sacri-
ficed
(days)
Prickle
Ce PrickleCellEpithel. Broder's Grade
Series Al, C- males, 3 months old. Dose: inc. to
0.1 cc. by 27 days, then 0.1 cc. for 140
days, then .05 cc.
1-3 395
1-8 444
1-2 447
11-9 447
11-90 447
444
444
447
447
447
—
—
—
+
—
+
+
+
—
+
II
II
I
I
Series A4-III, C- males, 2 months old. Dose:
.025 cc. for 30 days, then .05 cc.
111-7
111-9
111-13
111-5
111-12
111-10
111-4
111-i
187
240
327
413
456
—
231
327
228
240
398
413
456
202
231
398
—
+
—
—
—
—
—
—
+
—
+
+
—
—
+
+
IV
II
III
P.C. hyper-
plasia
IV
III
Series A4-IV, C- females, 2 months old.
Dose: as in series A4-III
IV-40 167 208 — + IV
IV-50 327 343 — + II
IV-4 400 434 — + IV
IV-60 450 484 — + III
IV-30 460 484 — + II
Series A6, C- females, 3 months old.
Dose: as in series A4-III
#1 330 359 — + III, fibro-
sarcoma3 330 359 — + II
#11 359 359 — + II
#8 380 409 — + II
#6 409 409 — + II
#9 409 409 — + I
Series A7, C- males, 3 months old. Dose:
as in series A4-III
#30 210 210 + —
#34 — 240 — —
#38 — 270 — —
#42 — 300 — —
#44 — 330 — —
TABLE IV
29 anthramine mice
(painted 202—484 days)
Prickle cell epithelioma 20
Broders grade I 3
grade II 9
grade III 4
grade IV 4
Prickle cell papilloma 3
Fibrosarcoma 1
No tumors 6
TABLE V
6 methylcholanthrene rats
Fisher albino male rats, 5 months old. Dosage:
0.3% MCA 3X/week (0.2—0.3 cc.) to midback.
.
I-'
ig
.
—
(ID
.
5
,
#29
#33
#37
#39
#41
#45
—
—
—
—
—
330
180
210
240
270
300
330
—
—
—
—
—
+
+
+
—
+
+
+
small superficial BCE*
small deep nest BCE
many fibroblasts in cutis
superficial and deep nests
BCE
small deep nests BCE
large cystic BCE's and
verrucous grade I
PCEt
Totals 6 1 5
* BCE—basal cell epithelioma
f PCE—prickle cell epithelioma
unchanged and showed no change in mast cell
content.
Methyicholanthrene Treated Mice
Biopsy specimens were taken up to 240 days.
Epidermal hyperplasia was present at 30 days
and was progressive, showing typical precancer-
ous changes. All mice sacrificed from 120 days on
had squamous cell carcinomas. No sebaceous
glands were found at 30 days, but were present in
all later specimens. There was an increase in
mast cell infiltration accompanying the epidermal
hyperplasia and development of the squamous
cell carcinomas.
Enzyme Studies
All monthly biopsy specimens of rats and mice
and a number of tumors were tested histochemi-
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FIG. 20. Superficial basal cell epithelioma. Methyicholanthrene painted rat, 270 days, (A7-39). H&E,
180X.
cally for non-specific esterases and succinic de-
hydrogenase. Freshly removed tissue was
immediately frozen at —65° C. Sections were
cut at —25° C in a cryostat at 6 microns. The
tumors tested were 7 squamous cell carcinomas
in mice; 2 squamous carcinomas, 3 basal cell
epitheliomas, and one sebaceous adenoma in
rats.
For non-specific esterases, Pearson's technic
using 5-bromoindoxyl acetate as substrate was
used (6). In normal rats and mice, and in all
monthly biopsies of both species treated with
anthramine and methylcholanthrene activity was
found only in the sebaceous glands. There was no
activity in the epidermis, hair follicles, or cutis.
Both basal and squamous cell carcinolnas were
also negative. The sebaceous cells within a
sebaceous adenoma were positive.
Sections were also tested for .succinic dehydro-
genase using nitroneotetrazolium chloride as
substrate (7). In normal mice and rats and in
all monthly biopsies of both species in Exp. IV
activity was found only in certain parts of the
hair shaft and internal root sheaths, and in the
panniculus carnosus. There was otherwise no
activity in the epidermis, cutis or other cutaneous
appendages. The basal and squamous epitheli-
omas, and sebaceous adenoma were negative.
EXPERIMENT V. ANTHRAMINE TREATED
GUINEA PIGS
Five albino male guinea pigs weighing about
350 grams were treated with the anthramine
—
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-
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FIG. 21. Basal cell nest apparently arising from
hair follicle. Methyicholanthrene painted rat, 210
days, (A7-33). H&E, 180X.
FIG. 22. Two deep basal cell growths just above
panniculus carnosus. Methylcholanthrene painted
rat, 270 days, (A7-39). H&E, 90X.
solution for 349 days. The solution was applied
to the unshaved and unepilated midback using
a syringe and blunt needle. The application was
twice weekly, gradually increasing the dose to
0.15 cc. by the 185th day, 0.3 cc. by the 297th
day, and then 0.25 cc. 5 days weekly until the
349th day when treatment was discontinued.
Three animals were sacrificed at 480 days and
two at 652 days. No gross or microscopic tumors
of the skin were found. No hair loss occurred in
the treated areas.
FIG. 23. Large basal cell mass with keratin
whorls, cysts, and liquefaction degeneration.
Methylcholanthrene painted rat, 330 days, (A7-
45). H&E.
DISCUSSION
Whereas Lennox (3) found sarcomas to be
the most common tumors in his series of anthra-
mine painted rats, followed by the squamous,
basal and sebaceous groups, in our experiments
basal cell neoplasms were the most frequent
followed by squamous tumors, sebaceous growths,
and sarcomas. An explanation of these differ-
ences may lie in the fact that a higher percentage
of our rats were sacrificed at an earlier date than
in Lennox's study. Five of the rats with basalio-
mas had no visible tumors when sacrificed and
the lesions were found only on microscopic ex-
amination. Some speculation may be in order as
to why the basal cell lesions appeared first. Can
they be evoked by a smaller carcinogenic stimulus
than required for squamous lesions? Or is their
development related to the longer persistence of
hair growth in the rat as contrasted to the mouse
in which hair loss occurred earlier and in which
only squamous lesions developed? Or does this
simply represent a difference between species in
the typical response to a carcinogen?
The experimental production of basal cell
growths gives one the opportunity to study the
very early development of these lesions. We were
impressed by the multiple foci of small basal
cell proliferations from the epidermis as well as
from deeper portions of the hair follicles. We
were also struck by the early fibroblastic pro-
liferations accompanying these lesions. This
mutual relationship of basal cell epitheliomas and
__
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its connective tissue stroma, as emphasized by
Pinkus (8), was obvious in more fully dcveloped
lesions as well.
The finding of basal cell nests with hyalin
degeneration and suggesting somewhat the picture
of human cylindromas may be of some theoreti-
cal interest since the rat has no apocrine sweat
glands and has eccrine sweat glands only on the
digital paws (9).
The occurrence of sebaceous adenomas in the
antbramine treated rats together with the re-
ports that related aromatic amines either by
oral administration or subcutaneous injection
produce tumors of the acoustic sebaceous gland
in the rat (10, 11) raises the question as to
whether these compounds have a direct stimulat-
ing effect on sebaceous glands.
In Lennox's group of anthramine treated mice,
8 had squamous cell lesions of which only 2 were
carcinomas. However, all of his mice had to be
sacrificed at 265 days because of salmonella in-
fection. Fortunately, we were able to keep our
mice up to 484 days, and 20 out of 29 developed
squamous cell carcinomas. However, in view of
the long period required to produce these squa-
mous tumors it is obvious that anthramine is a
weak carcinogen for mouse skin, as compared to
methylcholanthrcne.
The finding of basaliomas in 5 of 6 rats painted
with methylcholanthrene was something of a
surprise in view of the general feeling that the
rat is relatively resistant to topical carcinogens.
The mouse has been the animal of choice in ex-
perimental carcinogencsis in view of the ease in
producing squamous cell carcinomas by topical
carcinogens. However, for the investigative
dermatologist we believe the rat is a much more
fruitful subject in view of the wide variety of
cutaneous tumors that can be produced.
That both basal and squamous carcinomas
can be produced in the rat by anthramine,
methylcholanthrene, and, apparently, also by
beta rays (12) would indicate that it is more the
host response to the carcinogenic stimulus,
rather than the specific nature of the carcinogen
that determines the type of neoplasm produced.
In this connection the recent report of Cannon,
at at., in which 14 of 36 cases of skin cancer fol-
lowing x-ray therapy for benign skin conditions
were basal cell epithcliomas (13) should be men-
tioned. In view of the experimental production
of basal cell cpitheliomas by a variety of agents,
as well as its occurrence following x-ray therapy
and other external agents, we do not believe that
these tumors can be strictly regarded as nevoid
disturbances.
SUMMARy
1. Of 24 rats painted for 180—40 1 days with
2-anthraminc, basal cell epithcliomas were found
in 20, sebaceous adenomas in 6, scbaccous cpi-
theliomas in 3, prickle cell carcinomas in 9,
prickle cell papillomas in 3, fibrosarcomas in 4,
and "cylindromas" in 3. Nine rats had both
basal and squamous carcinomas. Basal cell pro-
lifcrations were the first to appear.
2. Of 29 mice painted with anthramine for
202—484 days, prickle cell carcinomas were found
in 20, squamous papillomas in 3, and a fibro-
sarcoma in one. No basal cell epitheliomas were
found in the mice.
3. Of 6 rats painted with mcthylcholanthrcne
for 180—330 days, 5 developed basal ccli epi-
theliomas and one also had a squamous cell
epithelioma.
4. No tumors were found in 5 guinea pigs
painted for 349 days with anthramine.
5. Findings are reported of monthly biopsy
specimens taken of rats and mice painted with
both anthramine and mcthylcholanthrene prior
to the development of tumors. These were
stained by 3 different technics and tested histo-
chemically for non-specific csterascs and succinic
dchydrogcnasc.
6. No non-specific cstcrase or succinic dehy-
drogenasc activity was found in the basal or
squamous cell cpitheliomas.
7. The implications of these findings as they
relate to the genesis of basal cell epitheliomas in
humans are discussed.
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DISCUSSION
DR. JOHN M. KNOX (Houston, Texas): This
was a very interesting presentation and a chal-
lenging one. I would like to philosophize as to
why the experiments by our group and those by
Dr. Winkelmann yielded primarily squamous
cell carcinomas; whereas, Drs. Zaekheim and
Simpson have produced many different types of
hamartoma and carcinoma in their experiments.
First, different carcinogenic agents were em-
ployed, and second, we used only hairless areas
of the mice. Thirdly, the anthramine and methyl-
eholanthrene were applied to shaved areas that
had numerous hair follicles. Possibly the differ-
ence is purely anatomical. Many people have
stated that basal cell epitheliomas do not form
as a result of chronic exposure to radiation. I
certainly believe the basal cell as well as the
squamous cell epitheliomas result from chronic
irradiation by sunlight.
DR. HARRY L. ARNOLD, JR. (Honolulu,
Hawaii): Dr. Knox's remarks lent a little more
color to what I want to say. I want to point out
that here we have had a demonstration of a
Carcinogen which is so specific that it is much
less effective in the mouse than in the rat. Cer-
tainly the mouse is more like a rat than a human
is like an albino mouse, and it might be pointed
out that the psoralen aggravation of sun ex-
posure was only demonstrated in albino mice.
So far as I know it has not been demonstrated
with mice with pigment in their skin.
As Dr. Sutton Zackheim mentioned, the way
to know something can happen is to know it has
happened. I know of no one who knows the
psoralens have done any hàrm to anybody except
to induce severe sunburns if they were imprudent
about the dose of either the drug or the sunlight.
The incidence of liver damage which has been
alluded to seems to have been pretty largely
a laboratory phenomenon which is not only
confined to the laboratory but also temporary
and transitory, and as far as I know, nobody
has even suggested any evidence that the psora-
lens are likely to aggravate the potentiality of
sunlight to produce cancer in human skin.
Finally, the one remark of Dr. Winkelmann in
this connection, that he felt the total amount of
radiation, not the intensity, influenced carcino-
genesis, should be seriously questioned. I know
that is not true except in a very broad way with
x-radiation: that it is the intensity, by and
large, which is much the most important factor
in influencing earcinogenesis. It has been my
experience in Hawaii over 20 years, people in
sunlight, that people who are imprudent about
getting sunburns are almost invariably the ones
who get into trouble with skin cancer. The people
whose total exposure to sunlight is extremely
large over long periods of time, but get it gradu-
ally, and don't get sunburn, are not in much
trouble.
DR. ALFRED ELlAssow (Kew Gardens, N. Y.):
I have only one question, which refers also to
the presentation of Dr. Winkelmann. I wonder
whether the skin tumors ever disappeared when
the application of the carcinogenic substance was
discontinued. My question is, whether these
processes were ever found to be reversible?
DR. WALTER F. LEvER (Boston, Mass.): This
paper is of interest. Now we know that basal
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cell epitheliomas can be caused not only by the
ingestion of arsenic, by exposure to sun and by
exposure to x-ray, but also by the external
application of chemicals. However, I would say
it does not prove that basal cell epitheliomas
are true carcinomas and one should be a, little
careful in the use of the word "carcinogenesis".
Among the tumors that were produced by
Dr. Zackheim and collaborators were also
adenomas. They thus observed a general increase
in tumor genesis, not just in carcinogenesis. I
would still adhere to the idea that basal cell
epitheliomas are not true carcinomas but repre-
sent a proliferation of immature embryonic cells
rather than of malignant anaplastic cells.
Da. STEPHEN ROTHMAN (Chicago, Ill.): In
contrast to Dr. Arnold I do not believe the
safety of psoralen medication has been proved.
Lerner et al. (J. Invest. Dermat., 20: 299, 1953)
and George and Burks (A.M.A. Arch Derm.,
71: 14, 1955) have recorded development of
laboratory signs of liver damage. Also, 1 do
believe that Harold Blum has demonstrated
that carcinogenesis depends on the total radia-
tion energy only and I doubt that repeated sun-
burn reactions are a necessary prerequisite for
actinic cancer formation. Chronic slow exposure
is equally dangerous.
DR. HERSCHEL S. ZACKHEIM (in closing): I
wish to thank the discussers for their remarks.
In regard to Dr. Knox's question, he was prob-
ably misled by the picture. Neither the mice
nor rats were shaved prior to therapy but alo-
pecia does develop after a period of time and this
is an interesting point. In fact in the mice we
noticed hair loss in about three months after
the onset of therapy. In rats there was no sig-
nificant hair loss until at least seven months.
This possibly may be part of the explanation as
to why the rats develop basal cell epitheliomas
and mice squamous cell cancers. I am not sure.
We did not notice any involution of tumors or
reversing of the process as long as we followed
them.
With regard to Dr. Lever's comment, we do
not regard basal cell proliferations as true car-
cinomas and possibly we use the term synony-
mously too loosely. I agree with the concept of
the term "epithelioma" as being much more
accurate for the basal cell lesions. We did not
find any metastases in any of the anthramine
treated rats.
